news
Cantor Fitzgerald Maintains Salesforce(CRM.US) With Buy Rating, Maintains Target Price $250
Wall Street still loves Salesforce. Your ops team does not. Cantor Fitzgerald just reaffirmed their Buy rating on Salesforce with a $250 price target. Analysts are confident in the stock. That's fine

Wall Street still loves Salesforce. Your ops team does not.
Cantor Fitzgerald just reaffirmed their Buy rating on Salesforce with a $250 price target. Analysts are confident in the stock. That's fine for investors.
But you're not buying the stock. You're buying the software — and those are two very different experiences.
A high price target means the business is healthy. It says nothing about whether your team can actually change a workflow without filing a support ticket, waiting three weeks, and paying a consultant $15K to move a field.
If you've been through the Salesforce customization cycle before — the implementation partner, the long timeline, the moment six months later when you realize you just rebuilt the same problems with a bigger price tag — you already know what analyst ratings don't capture.
The frustration isn't with CRM as a category. It's with software that was built to impress buyers during a demo, not to fit how your business actually runs the day after go-live.
A stock being worth $250 a share and a platform being worth your team's time are questions with completely different answers.
#CRM #SalesOperations #MidMarket #SalesforceAlternatives #RevOps
Original Source
CantorFitzgerald analyst Matthew VanVliet maintains $Salesforce(CRM.US)$ with a buy rating, and maintains the target price at $250.